Literature DB >> 25502484

Genetic overlap between antipsychotic response and susceptibility to schizophrenia.

Masashi Ikeda1, Reiji Yoshimura, Ryota Hashimoto, Kenji Kondo, Takeo Saito, Ayu Shimasaki, Kazutaka Ohi, Mamoru Tochigi, Yoshiya Kawamura, Nao Nishida, Taku Miyagawa, Tsukasa Sasaki, Katsushi Tokunaga, Kiyoto Kasai, Masatoshi Takeda, Jun Nakamura, Norio Ozaki, Nakao Iwata.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25502484     DOI： 10.1097/JCP.0000000000000268

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN： 0271-0749            Impact factor:   3.153


× No keyword cloud information.
  5 in total

Review 1.  Clozapine as a Model for Antipsychotic Development.

Authors:  Frederick C Nucifora; Marina Mihaljevic; Brian J Lee; Akira Sawa
Journal:  Neurotherapeutics       Date:  2017-07       Impact factor: 7.620

Review 2.  Treatment resistant schizophrenia: Clinical, biological, and therapeutic perspectives.

Authors:  Frederick C Nucifora; Edgar Woznica; Brian J Lee; Nicola Cascella; Akira Sawa
Journal:  Neurobiol Dis       Date:  2018-08-29       Impact factor: 5.996

Review 3.  Treatment-resistant schizophrenia: current insights on the pharmacogenomics of antipsychotics.

Authors:  John Lally; Fiona Gaughran; Philip Timms; Sarah R Curran
Journal:  Pharmgenomics Pers Med       Date:  2016-11-07

Review 4.  Clozapine Pharmacogenetic Studies in Schizophrenia: Efficacy and Agranulocytosis.

Authors:  Shusuke Numata; Hidehiro Umehara; Tetsuro Ohmori; Ryota Hashimoto
Journal:  Front Pharmacol       Date:  2018-09-26       Impact factor: 5.810

Review 5.  Neuroimaging studies within Cognitive Genetics Collaborative Research Organization aiming to replicate and extend works of ENIGMA.

Authors:  Daisuke Koshiyama; Kenichiro Miura; Kiyotaka Nemoto; Naohiro Okada; Junya Matsumoto; Masaki Fukunaga; Ryota Hashimoto
Journal:  Hum Brain Mapp       Date:  2020-06-05       Impact factor: 5.038
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.